A firm headquartered in China with an additional office in USA, is currently managing a venture capital fund in RMB with a total of 500 MM RMB (~70MM USD). The firm is currently focusing on the early-stage (from angel to series B) investments, with initial investment ranging from 3MM RMB (400,000 USD) to 5MM RMB (700,000 USD). The management team supports the firm with decades of experience in both the U.S. and China and is open to investing globally.
The firm has a general interest in the early-stage life science technology assets, especially therapeutics and medical devices. The fund also opens to diagnostics and healthcare IT, with the proven record of investing in hospital AI service platforms.
The firm prefers companies with China Angle, especially companies who are willing to register an entity/branch/joint venture in China.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Leave a Reply